CONCENTRATIONS OF CEFTRIAXONE IN CEREBROSPINAL-FLUID OF CHILDREN WITH MENINGITIS RECEIVING DEXAMETHASONE THERAPY

被引:38
作者
GAILLARD, JL
ABADIE, V
CHERON, G
LACAILLE, F
MAHUT, B
SILLY, C
MATHA, V
COUSTERE, C
LOKIEC, F
机构
[1] HOP NECKER ENFANTS MALAD,DEPT PEDIAT,F-75743 PARIS 15,FRANCE
[2] CTR RENE HUGUENIN,SERV PHARMACOL CLIN,F-92210 ST CLOUD,FRANCE
关键词
D O I
10.1128/AAC.38.5.1209
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The penetration of ceftriaxone into cerebrospinal fluid (CSF) was studied with 11 children (mean age: 2 years, 4 months; range: 4 months to 8 years),vith meningitis, receiving dexamethasone (0.15 mg/kg of body weight intravenously four times daily) as adjunctive therapy. Ceftriaxone was given intravenously at doses of 50 mg/kg twice daily to patients <18 months old and 100 mg/kg once daily to patients greater than or equal to 18 months old. CSF was collected after 1 day of treatment at the expected peak concentration of ceftriaxone in CSF. Concentrations of ceftriaxone in CSP ranged from 0.7 to 9.2 mg/liter, with a mean value of 4.0 (standard deviation [SD], 2.9) mg/liter. Values were significantly higher for patients with CSF glucose levels of <1 mmol/liter on admission to the hospital than for patients with CSF glucose levels of greater than or equal to 1 mmol/liter (mean values of 7.1 [SD, 2.2] mg/liter versus 2.2 [SD, 1.1] mg/liter; P < 0.001). After 1 day of treatment, ceftriaxone concentrations in the CSF of children receiving dexamethasone are similar to the mean values reported for children not treated with dexamethasone.
引用
收藏
页码:1209 / 1210
页数:2
相关论文
共 16 条
[1]   PENETRATION OF ANTIBIOTICS INTO CEREBROSPINAL-FLUID AND BRAIN-TISSUE [J].
BARLING, RWA ;
SELKON, JB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (03) :203-227
[2]  
BRADY MT, 1991, J PEDIATR, V99, P924
[3]  
CHERUBIN CE, 1989, REV INFECT DIS, V11, P526
[4]  
DELRIO MDA, 1983, LANCET, V1, P1241
[5]   CEFTRIAXONE DIFFUSION INTO CEREBROSPINAL-FLUID OF CHILDREN WITH MENINGITIS [J].
LATIF, R ;
DAJANI, AS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :46-48
[6]  
LEBEL MH, 1989, PEDIATRICS, V83, P161
[7]   PHARMACOKINETICS OF CEFTRIAXONE IN NEONATES AND INFANTS WITH MENINGITIS [J].
MARTIN, E ;
KOUP, JR ;
PARAVICINI, U ;
STOECKEL, K .
JOURNAL OF PEDIATRICS, 1984, 105 (03) :475-481
[8]   CURRENT MANAGEMENT OF BACTERIAL-MENINGITIS IN INFANTS AND CHILDREN [J].
MCCRACKEN, GH .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (02) :169-174
[9]   MODULATION OF INFLAMMATION AND CACHECTIN ACTIVITY IN RELATION TO TREATMENT OF EXPERIMENTAL HEMOPHILUS-INFLUENZAE TYPE-B MENINGITIS [J].
MUSTAFA, MM ;
RAMILO, O ;
MERTSOLA, J ;
RISSER, RC ;
BEUTLER, B ;
HANSEN, EJ ;
MCCRACKEN, GH .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (05) :818-825
[10]   CEREBROSPINAL-FLUID PROSTAGLANDINS, INTERLEUKIN-1-BETA, AND TUMOR-NECROSIS-FACTOR IN BACTERIAL-MENINGITIS - CLINICAL AND LABORATORY CORRELATIONS IN PLACEBO-TREATED AND DEXAMETHASONE-TREATED PATIENTS [J].
MUSTAFA, MM ;
RAMILO, O ;
SAEZLLORENS, X ;
OLSEN, KD ;
MAGNESS, RR ;
MCCRACKEN, GH .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (08) :883-887